ARCHIVES

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 32 No. 46 | December 22, 2006

Download PDF Visit The Full Archive

Related Articles

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

Women Are Less Active After A Diagnosis of Breast Cancer

March 28, 2003

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Sanofi Responds to Criticism From Oncologists

November 8, 2012

In Brief: Charles Smart To Give Up Commission On Cancer Post, Kansas Surgeon To Become Fulltime Director

April 15, 1983

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003